Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer

OBJECTIVES: Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer (NSCLC). However, obtaining tumor tissue for mutation analysis is challenging. Here, we aimed to detect serum peptides/prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lin, Tang, Chuanhao, Xu, Bin, Wang, Weixia, Li, Jianjie, Li, Xiaoyan, Qin, Haifeng, Gao, Hongjun, He, Kun, Song, Santai, Liu, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457791/
https://www.ncbi.nlm.nih.gov/pubmed/26047516
http://dx.doi.org/10.1371/journal.pone.0128970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457791/
https://www.ncbi.nlm.nih.gov/pubmed/26047516
http://dx.doi.org/10.1371/journal.pone.0128970

Ejemplares similares